Cargando…
A Pharmacometric Analysis of Patient-Reported Outcomes in Breast Cancer Patients Through Item Response Theory
PURPOSE: An item response theory (IRT) pharmacometric framework is presented to characterize Functional Assessment of Cancer Therapy-Breast (FACT-B) data in locally-advanced or metastatic breast cancer patients treated with ado-trastuzumab emtansine (T-DM1) or capecitabine-plus-lapatinib. METHODS: I...
Autores principales: | Schindler, Emilie, Friberg, Lena E., Lum, Bertram L., Wang, Bei, Quartino, Angelica, Li, Chunze, Girish, Sandhya, Jin, Jin Y., Karlsson, Mats O. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer US
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5908825/ https://www.ncbi.nlm.nih.gov/pubmed/29675616 http://dx.doi.org/10.1007/s11095-018-2403-8 |
Ejemplares similares
-
Multistate model for pharmacometric analyses of overall survival in HER2‐negative breast cancer patients treated with docetaxel
por: Krishnan, Sreenath M., et al.
Publicado: (2021) -
Improved Utilization of ADAS-Cog Assessment Data Through Item Response Theory Based Pharmacometric Modeling
por: Ueckert, Sebastian, et al.
Publicado: (2014) -
A Pharmacometric Framework for Axitinib Exposure, Efficacy, and Safety in Metastatic Renal Cell Carcinoma Patients
por: Schindler, E, et al.
Publicado: (2017) -
Population pharmacokinetic and exploratory exposure–response analysis of the fixed-dose combination of pertuzumab and trastuzumab for subcutaneous injection in patients with HER2-positive early breast cancer in the FeDeriCa study
por: Wang, Bei, et al.
Publicado: (2021) -
Generation and application of avatars in pharmacometric modelling
por: Chasseloup, Estelle, et al.
Publicado: (2023)